MedTrace Logo

Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women

NCT01526278 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-02-25

No results posted yet for this study

Summary

This study will evaluate clinical safety and pharmacokinetics of Maxmarvil® in healthy postmenopausal women

Conditions

Interventions

DRUG

Maxmarvil®

Drug : Maxmarvil® 1tablet one time in clinical trial, PO medication

Sponsors & Collaborators

  • Yuyu Pharma, Inc.

    lead INDUSTRY

Principal Investigators

  • yoon-suk chung, MD,PhD · Ajou university hospotal

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-07-31
Completion
2012-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01526278 on ClinicalTrials.gov